I-MED Surgical introduces RaySert®, Small-Incision IOL Injector System in Canada
06/30/2011

I-MED Surgical, a division of I-MED Pharma Inc., (I-MED) in partnership with Rayner Intraocular Lenses Limited (Rayner)has introduced *RaySert®, a small-incision IOL injector system. With a 1.8-mm diameter external tip, RaySert® enables surgeons to insert an IOL through a sub-2.5-mm incision, reducing surgically induced astigmatism.

Online PR News – 30-June-2011 – – I-MED Surgical, a division of I-MED Pharma Inc., (I-MED) in partnership with Rayner Intraocular Lenses Limited (Rayner) has introduced RaySert®, a small-incision IOL injector system in Canada. With a 1.8-mm diameter external tip, RaySert® enables surgeons to insert an IOL through a sub-2.5-mm incision, reducing surgically induced astigmatism.

Designed for use initially with the Rayner’s C-flex® range of IOLs, RaySert® assures ease of use with controlled delivery through a convenient single-handed injection system. Surgeons can perform cataract surgery using truly small surgical incisions, using the RaySert®, to enhance patient comfort and recovery.

The basic premise of RaySert® is to enable the implantation of Rayner IOLs through the smallest possible incision size, thus guaranteeing the optimal relationship between IOL design and incision size. This is an important dynamic according to Mark Packer, MD: “The specific features of the IOL represent mountains in comparison to the molehills of the incision size. We often say, ‘The patient will never know – or care – if the lens went through a 2, 3 or 4-mm incision. The patient will care about the long-term quality of vision.’”

“As an innovator in IOL technology, the introduction of the RaySert® small-incision injector system is a natural progression, in delivering physicians with a new level of control and ease in IOL delivery. It is yet another milestone in Rayner’s commitment to optimize the accuracy and safety of IOL surgery outcomes,” says Donald J. Munro, Chairman and Managing Director, Rayner.

RaySert® is available for sales in Canada as a single-use injector.

About I-MED

I-MED Pharma innovates, manufactures and distributes medical, surgical and veterinary eye care products. I-MED remains uniquely focused on ophthalmology and is divided into three functional business units: Surgical, Pharma and Animal Health Divisions. It researches, develops, manufactures and sources the most effective and advanced solutions to eye disorders like cataracts, refractive surgery, corneal transplants, dry eye, and glaucoma.

For more information please visit www.imedpharma.com.